공시 • Jan 22
EBOS Group Limited to Report First Half, 2026 Results on Feb 25, 2026 EBOS Group Limited announced that they will report first half, 2026 results on Feb 25, 2026 공시 • Aug 28
EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd. EBOS Group Limited (NZSE:EBO) acquired Next Generation Pet Foods Pty Ltd for AUD 43 million on July 1, 2025. A cash consideration of AUD 43 million will be paid by EBOS Group Limited. As part of consideration, AUD 43 million is paid towards common equity of Next Generation Pet Foods Pty Ltd. The deal was fully funded through existing debt facilities and cash on hand. The transaction is expected to be marginally EPS accretive in the first year.
EBOS Group Limited (NZSE:EBO) completed the acquisition of Next Generation Pet Foods Pty Ltd on July 1, 2025. 공시 • Aug 15
EBOS Group Limited, Annual General Meeting, Oct 29, 2025 EBOS Group Limited, Annual General Meeting, Oct 29, 2025. Location: at the park hyatt hotel, 99 halsey street, auckland New Zealand 공시 • Jun 03
EBOS Group Limited to Report Fiscal Year 2025 Results on Aug 27, 2025 EBOS Group Limited announced that they will report fiscal year 2025 results on Aug 27, 2025 공시 • May 12
EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million. EBOS Group Limited has completed a Follow-on Equity Offering in the amount of AUD 54.272 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 1,600,000
Price\Range: AUD 33.92 공시 • Apr 11
EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million. EBOS Group Limited has completed a Follow-on Equity Offering in the amount of NZD 217.220005 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 5,926,876
Price\Range: NZD 36.65
Discount Per Security: NZD 0.69635
Transaction Features: Regulation S; Subsequent Direct Listing 공시 • Jan 31
EBOS Group Limited Announces Appointment of Coline Mcconville as A Director, Effective 1 February 2025 EBOS Group Limited announced the appointment of Coline Mcconville as A Director, Effective 1 February 2025. 공시 • Jan 22
EBOS Group Limited Appoints Grant Viney as Chief Executive Officer of EBOS Animal Care , Effective 1 February 2025 EBOS Group Limited announced the appointment of Mr. Grant Viney to the role of Chief Executive Officer of EBOS Animal Care with effect from 1 February 2025. Mr. Viney is currently the Executive General Manager of EBOS-owned Masterpet, having joined the business in 2019. The business, which includes premium natural pet food brand, Black Hawk, and the Vitapet food and treats range, has experienced strong and consistent growth under Mr. Viney's management. Before joining EBOS, Mr. Viney held senior roles at leading FMCG companies including Accolade Wines, PZ Cussons, Dairy Farmers Australia and Mars Confectionary. 공시 • Jan 14
EBOS Group Limited to Report First Half, 2025 Results on Jan 19, 2025 EBOS Group Limited announced that they will report first half, 2025 results on Jan 19, 2025 공시 • Jan 03
EBOS Group Limited Appoints Matthew Muscio as Director EBOS Group Limited announced the appointment of Matthew Muscio as director. Date of appointment is 1 January 2025. 공시 • Aug 23
EBOS Group Limited Announces Final Dividend, Payable on 18 September 2024 EBOS Group Limited announced final dividend of NZD 0.61500000 per share. Dividend Payment Date is 18 September 2024. Record Date is 30 August 2024. Ex-Date is 29 August 2024. 공시 • Apr 27
EBOS Group Limited Announces Chief Financial Officer Changes EBOS Group Limited announced the appointment of Alistair Gray to the role of Chief Financial Officer (CFO) with effect from 30 September 2024. Mr. Gray is currently Deputy CFO at Endeavour Group. Mr. Gray joined Endeavour Group in 2018 just prior to the demerger from Woolworths and is responsible for the Group finance teams. Prior to Endeavour he held senior roles at Toll Group, Mondelez International and Coles and throughout his career has accumulated a wealth of consumer, retail and supply chain experience across Australia, New Zealand, the UK and Asia. Mr. Gray will be based at company’ Melbourne office. In announcing Mr. Gray’s appointment, the company also announced that its current CFO, Leonard Hansen, will move from the CFO role and continue with the company in the capacity of Chief Risk Officer (CRO). Leonard Hansen will continue in the role of the company’s CFO until Mr. Gray’s commencement in September. 공시 • Jan 10
EBOS Group Limited to Report First Half, 2024 Results on Feb 21, 2024 EBOS Group Limited announced that they will report first half, 2024 results on Feb 21, 2024 공시 • Dec 20
EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million. EBOS Group Limited (NZSE:EBO) acquired additional 39% stake in Transmedic Pte Ltd. from TS Lee for approximately SGD 120 million on December 19, 2023. The purchase price was funded from existing debt facilities and the transaction is expected to be immediately marginally EPS accretive.
EBOS Group Limited (NZSE:EBO) completed the acquisition of additional 39% stake in Transmedic Pte Ltd. from TS Lee on December 19, 2023. 공시 • Dec 15
Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk Paragon Care Limited (ASX:PGC) is understood to have hired Rothschild & Co as a defence adviser amid chatter in the market it has been in the cross hairs of EBOS Group Limited (NZSE:EBO). There's talk in the market that Paragon has bidders interested in the business at 40c a share. Paragon Care shares closed up 2.3% to 22c on 13 December 2023. Earlier, Paragon had said that it had not received approaches from EBOS, while both groups declined to comment on 13 December 2023. Its market value is $147 million. As earlier reported by DataRoom, EBOS held talks about a backdoor listing involving Chemist Warehouse, but instead, the pharmacy giant embarked on the $8 billion-plus move through EBOS's rival Sigma Healthcare. 공시 • Dec 07
EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit EBOS Group Limited (NZSE:EBO) seems to be moving on quickly from its $4 billion courtship of Greencross Limited, with talk that it is eyeing Paragon Care Limited (ASX:PGC). While small, with just a $113.5 million market value, Paragon Care operates in the areas of specialty diagnostics and devices under brands such as Designs for Vision, Electro Medical Group, Specialist Medical Supplies and Immulab. Apparently, there's a large Asian private equity firm also interested in buying the business right now. However, should there be interest in Paragon it is likely to be early days, with sources close to the company saying it has not received approaches. Sources say the group has been yet to prove to the market it can deliver on its mergers and acquisition strategy. Other parties that have looked at Paragon in the past are Navis Capital, which now owns Device Technologies. 공시 • Nov 24
EBOS Not to Proceed with Acquisition in Animal Care Segment New Zealand EBOS Group Limited (NZSE:EBO) will not proceed with the potential transaction related to its animal care segment, the healthcare products distributor said on November 22, 2023. The announcement comes after local media reported the company would acquire TPG Capital-backed pets and vets business Greencross Limited. 공시 • Sep 27
EBOS Group Limited Announces Fully Franked Ordinary Dividend for the Six Months Ended June 30, 2023, Payable on 29 September, 2023 EBOS Group Limited announced Fully Franked Ordinary dividend for the six months ended June 30, 2023 of NZD 0.59514706 with Record Date 8 September, 2023; Ex Date 7 September, 2023 and Payment Date to be 29 September, 2023. 
